Inflammation is a manifestation of immune system activation, and there is growing evidence that the development of MDD is associated with immune activation, such as elevated levels of pro-inflammatory cytokines like IL-6 and TNF, which decrease after treatment [9, 10]. The gene discussed is TNF; the disease is major depressive disorder.